Dyfyniad APA

Steven, S., Oelze, M., Hanf, A., Kröller-Schön, S., Kashani, F., Roohani, S., . . . Daiber, A. (2017). The SGLT2 inhibitor empagliflozin improves the primary diabetic complications in ZDF rats. Redox Biol.

Dyfyniad Arddull Chicago

Steven, Sebastian, et al. "The SGLT2 Inhibitor Empagliflozin Improves the Primary Diabetic Complications in ZDF Rats." Redox Biol 2017.

Dyfyniad MLA

Steven, Sebastian, et al. "The SGLT2 Inhibitor Empagliflozin Improves the Primary Diabetic Complications in ZDF Rats." Redox Biol 2017.

Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.